The Texas A&M University System

The Texas A&M University System

The Texas A&M University System

Overview
Date Founded

1876

Headquarters

600 John Kimbrough Boulevard, College Station, Texas, 77843

Employees (Worldwide)

251 - 500

Industries

Investment Services & Portfolio Management

Company Description

The Texas A&M University System is one of the largest systems of higher education in the nation.

Contact Data
Trying to get in touch with decision makers at The Texas A&M University System? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Owner & Principal

Owner

Chief Executive Officer

Executive Director, Office of Sponsored Research Services

Executive Director

Executive Director

Provost

Chief Liaison Officer

General Manager

Partner

Board of Directors

Founder at Conceptual MindWorks, Inc.

President at Phil Adams Company

Distinguished Alumni
Clay Holderman is now Executive Vice President & Chief Operating Officer at Presbyterian Healthcare Services Corp.
Paths to The Texas A&M University System
Potential Connections via
Relationship Science
You
The Texas A&M University System
Clients

ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of a diverse portfolio of cancer therapies. It focuses on developing products in immuno-oncology that employ novel gene expression, control, and cell technologies for the treatment of cancer. The company was founded on September 9, 2003 and is headquartered in Boston, MA.

Ceres, Inc. develops and markets seeds and traits to produce crops for feed, forages, sugar and other markets. It uses a combination of plant breeding, biotechnology and bioinformatics to develop seed products and biotechnology traits. The company was founded by Walter De Logi, Richard William Hamilton and Robert B. Goldberg in 1996 and is headquartered in Thousand Oaks, CA.

Non-Profit Donations & Grants Received
Political Donations
$1,000
2007
$500
2006
$75
2001
Investments
Details Hidden

Global Biodiagnostics Corp. develops, manufactures, and distributes diagnostics that address huge needs in the global infectious disease market. Its TB diagnostic platform incorporates a biophotonic detection technology that utilizes Reporter Enzyme Fluorescence (REF) to detect beta lactamase produced by live bacteria. The company was founded by Michael T. Norman and Chris N. Thornton in 2009 and is headquartered in Temple, TX.

Details Hidden

Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by The Texas A&M University System. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of The Texas A&M University System's profile does not indicate a business or promotional relationship of any kind between RelSci and The Texas A&M University System.